Stockreport

Immunic to Participate in Scientific and Medical Conferences in April [TheStreet.com]

Immunic, Inc.  (IMUX) 
PDF NEW YORK April 9, 2026 /PRNewswire/ -- Immunic , Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurolog [Read more]